Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bio Green Med Solution (BGMS) Gains from Investment Securities (2018 - 2025)

Historic Gains from Investment Securities for Bio Green Med Solution (BGMS) over the last 15 years, with Q3 2025 value amounting to $24937.0.

  • Bio Green Med Solution's Gains from Investment Securities changed N/A to $24937.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $24937.0, marking a year-over-year change of. This contributed to the annual value of $2000.0 for FY2024, which is 0.0% changed from last year.
  • Latest data reveals that Bio Green Med Solution reported Gains from Investment Securities of $24937.0 as of Q3 2025.
  • Bio Green Med Solution's Gains from Investment Securities' 5-year high stood at $6.1 million during Q1 2025, with a 5-year trough of $2000.0 in Q1 2023.
  • Its 5-year average for Gains from Investment Securities is $786403.2, with a median of $141903.0 in 2021.
  • In the last 5 years, Bio Green Med Solution's Gains from Investment Securities crashed by 9924.53% in 2023 and then surged by 4839792.0% in 2025.
  • Quarter analysis of 5 years shows Bio Green Med Solution's Gains from Investment Securities stood at $552153.0 in 2021, then fell by 5.4% to $522337.0 in 2022, then crashed by 99.62% to $2000.0 in 2023, then skyrocketed by 525.0% to $12500.0 in 2024, then soared by 99.5% to $24937.0 in 2025.
  • Its last three reported values are $24937.0 in Q3 2025, $25106.0 for Q2 2025, and $6.1 million during Q1 2025.